Molecular epidemiology of vancomycin-resistant Enterococcus faecium in Argentina

International Journal of Infectious Diseases

Volumn 11, Issue 1, 2007, Pages 69-75

  Corso, Alejandra C ^a   Gagetti, Paula S ^a   Rodríguez, Marisa M ^a   Melano, Roberto G ^a   Ceriana, Paola G ^a   Faccone, Diego F ^a   Galas, Marcelo F ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Argentina; Clonal dissemination; Enterococcus faecium; Glycopeptide resistance; Typing; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE;

ARGENTINA; ARTICLE; CONTROLLED STUDY; DILUTION; ENTEROCOCCUS FAECIUM; GENOTYPE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ARGENTINA; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; EPIDEMIOLOGY, MOLECULAR; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN RESISTANCE;

EID: 33845587600     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2006.02.003     Document Type: Article

References (42)

1. Leclercq R., Derlot E., Duval J., and Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319 (1988) 157-161
2. Uttley A.H., Collins C.H., Naidoo J., and George R.C. Vancomycin-resistant enterococci. Lancet 1 (1988) 57-58
3. Chadwick P.R., Woodford N., Kaczmarski E.B., Gray S., Barrell R.A., and Oppenheim B.A. Glycopeptide-resistant enterococci isolated from uncooked meat. J Antimicrob Chemother 38 (1996) 908-909
4. Coque T.M., Tomayko J.F., Ricke S.C., Okhuysen P.C., and Murray B.E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 40 (1996) 2605-2609
5. Stobberingh E.E., van den Bogaard A., London N., Driessen C., Top J., and Willems R.J. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of the Netherlands: evidence for transmission of vancomycin resistance from animals to humans?. Antimicrob Agents Chemother 43 (1999) 2215-2221
6. Centers for Disease Control and Prevention. National nosocomial infection surveillance (NNIS) system report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 29 (2001) 404-421
7. Cereda R., Gales A., Silbert S., Jones R., and Sader H. Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil. Infect Control Hosp Epidemiol 23 (2002) 19-22
8. Panesso D., Ospina S., Robledo J., Vela M.C., Peña J., Hernandez O., et al. First characterization of a cluster of vanA-type glycopeptide-resistant Enterococcus faecium. Colombia. Emerg Infect Dis 8 (2002) 961-965
9. Marin M.E., Mera J.R., Arduino R.C., Correa A.P., Coque T.M., Stamboulian D., et al. First report of vancomycin-resistant Enterococcus faecium isolated in Argentina. Clin Infect Dis 26 (1998) 235-236
10. Carvalho M., Teixeira L.M., and Facklam R.R. Use of tests for acidification of methyl-α-d-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera. J Clin Microbiol 36 (1998) 1584-1587
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards. Wayne, Pennsylvania, USA; 2000.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: twelfth informational supplement. Document M100-S12. National Committee for Clinical Laboratory Standards. Wayne, Pennsylvania, USA; 2002.
13. Dutka-Malen S., Evers S., and Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33 (1995) 24-27
14. Greisen K., Loeffelholz M., Purohit A., and Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 32 (1994) 335-351
15. Brown A.R., Townsley A.C., and Amyes S.G.B. Diversity of Tn1546 elements in clinical isolates of glycopeptide-resistant enterococci from Scottish hospitals. Antimicrob Agents Chemother 45 (2001) 1309-1311
16. De Lencastre H., Brown A.E., Chung M., Armstrong D., and Tomasz A. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital. Microb Drug Resist 5 (1999) 113-129
17. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
18. Miranda G., Corso A., Melano R., Arismendi P., Rodríguez M., and Garbervetsky L. Primer aislamiento de Enterococcus faecium vancomicina-resistente con genotipo vanB en la Argentina: presentación de dos casos. Rev Arg Microbiol 35 (2003) 41-44
19. Sader H.S., Pfaller M.A., Tenover F.C., Hollis R.J., and Jones R.N. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 32 (1994) 2840-2842
20. Chavers L.S., Moser S.A., Benjamin W.H., Banks Jr. S.E., Steinhauer J.R., Smith A.M., et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Inf 53 (2003) 159-171
21. Fridkin S.K., Yokoe D.S., Whitney C.G., Onderdonk A., and Hooper D.C. Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol 36 (1998) 965-970
22. Chow J.W., Kuritza A., Shlaes D.M., Green M., Sahm D.F., and Zervos M.J. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 31 (1993) 1609-1611
23. Nourse C., Byrne C., Kaufmann M., Keane C.T., Fenelon L., Smyth E.G., et al. VRE in the Republic of Ireland: clinical significance, characteristics and molecular similarity of isolates. J Hosp Inf 44 (2000) 288-293
24. Dunne Jr. W.M., and Wang W. Clonal dissemination and colony morphotype variation of vancomycin- resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol 35 (1997) 388-392
25. Cordeiro J.C.R., Silbert S., Reis A.O., and Sader H.S. Inter-hospital dissemination of glycopeptide-resistant Enterococcus faecalis in Brazil. Clin Microbiol Infect 10 (2004) 260-262
26. Del Campo R., Tenorio C., Zarazaga M., Gomez-Lus R., Baquero F., and Torres C. Detection of a single vanA-containing Enterococcus faecalis clone in hospitals in different regions in Spain. J Antimicrob Chemother 48 (2001) 746-747
27. Arthur M., Molinas C., Depardieu F., and Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 175 (1993) 117-127
28. Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 7 (2001) 229-236
29. Willems R.J., Top J., van den Braak N., van Belkum A., Mevius D.J., Hendriks G., et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 43 (1999) 483-491
30. Corso A., Faccone D., Gagetti P., Togneri A., Lopardo H., Melano R., et al. First report of vanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina. Int J Antimicrob Agents 25 (2004) 51-56
31. Cetinkaya Y., Falk P., and Mayhall C.G. Vancomycin-resistant enterococci. Clin Microbiol Rev 13 (2000) 686-707
32. Centers for Disease Control and Prevention. Recommendation for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morb Mortal Wkly Rep 44 (1995) 1-13
33. Harbarth S., Cosgrove S., and Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 46 (2002) 1619-1628
34. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb Mortal Wkly Rep 51 (2002) 565-567
35. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus-New York, 2004. Morb Mortal Wkly Rep 53 (2004) 322-323
36. Clark N., Weigel L.M., Patel J.B., and Tenover F.C. Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania. Antimicrob Agents Chemother 49 (2005) 470-472
37. Shankar N., Baghdayan A.S., and Gilmore M.S. Modulation of virulence within a pathogenicity island in vancomycin resistant Enterococcus faecalis. Nature 417 (2002) 746-750
38. Willems R.J., Homan W., Top J., van Santen-Verheuvel M., Tribe D., Manzioros X., et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357 (2001) 853-855
39. Leavis H.L., Top J., Shankar N., Borgen K., Bonten M., van Embden J., et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 186 (2004) 672-682
40. Harrington S.M., Ross T.L., Gebo K.A., and Merz W.G. Vancomycin resistance, esp, and strain relatedness: a 1-year study of enterococcal bacteremia. J Clin Microbiol 42 (2004) 5895-5898
41. Leavis H.L., Willems R.J., Top J., Spalburg E., Mascini E., Fluit A.C., et al. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 9 (2003) 1108-1115
42. Willems R.J., Top J., van Santen M., Robinson A., Coque T.M., Baquero F., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11 (2005) 821-828